I-Chun Chi

I-Chun Chi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Tsu-Man ChiuTsu-Man Chiu
Tsu-Man Chiu
YLYun-Chang Li
Yun-Chang Li
ICI-Chun Chi
I-Chun Chi
MTMing-Hseng Tseng
Ming-Hseng Tseng
Background: Skin cancer is the most common cancer worldwide, with melanoma being the deadliest type, though it accounts for less than 5% of cases. Traditional skin cancer detection methods are effective but are often costly and time-consuming. Recent advances in artificial intelligence have improved skin cancer diagnosis by helping dermatologists identify suspicious lesions. Methods: The study used datasets from two ethnic groups, sourced from the ISIC platform and CSMU Hospital, to develop an AI diagnostic model. Eight pre-trained models, including convolutional neural networks and vision transformers, were fine-tuned. The three best-performing models were combined into an ensemble model, which underwent multiple random experiments to ensure stability. To improve diagnostic accuracy and reduce false negatives, a two-stage classification strategy was employed: a three-class model for initial classification, followed by a binary model for secondary prediction of benign cases. Results: In the ISIC dataset, the false negative rate for malignant lesions was significantly reduced, and the number of malignant cases misclassified as benign dropped from 124 to 45. In the CSMUH dataset, false negatives for malignant cases were completely eliminated, reducing the number of misclassified malignant cases to zero, resulting in a notable improvement in diagnostic precision and a reduction in the false negative rate. Conclusions: Through the proposed method, the study demonstrated clear success in both datasets. First, a three-class AI model can assist doctors in distinguishing between melanoma patients who require urgent treatment, non-melanoma skin cancer patients who can be treated later, and benign cases that do not require intervention. Subsequently, a two-stage classification strategy effectively reduces false negatives in malignant lesions. These findings highlight the potential of AI technology in skin cancer diagnosis, particularly in resource-limited medical settings, where it could become a valuable clinical tool to improve diagnostic accuracy, reduce skin cancer mortality, and reduce healthcare costs.

29 August 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
Tsu-Man ChiuTsu-Man Chiu
Tsu-Man Chiu
ICI-Chun Chi
I-Chun Chi
YLYun-Chang Li
Yun-Chang Li
MTMing-Hseng Tseng
Ming-Hseng Tseng
The skin, the largest organ of the body, acts as a protective shield against external stimuli. Skin lesions, which can be the result of inflammation, infection, tumors, or autoimmune conditions, can appear as rashes, spots, lumps, or scales, or remain asymptomatic until they become severe. Conventional diagnostic approaches such as visual inspection and palpation often lack accuracy. Artificial intelligence (AI) improves diagnostic precision by analyzing large volumes of skin images to detect subtle patterns that clinicians may not recognize. This study presents a multiclass skin lesion diagnostic model developed using the CSMUH dataset, which focuses on the Eastern population. The dataset was categorized into seven disease classes for model training. A total of 25 pre-trained models, including convolutional neural networks (CNNs) and vision transformers (ViTs), were fine-tuned. The top three models were combined into an ensemble using the hard and soft voting methods. To ensure reliability, the model was tested through five randomized experiments and validated using the holdout technique. The proposed ensemble model, Swin-ViT-EfficientNetB4, achieved the highest test accuracy of 98.5%, demonstrating strong potential for accurate and early skin lesion diagnosis.